Histopathologische Diagnose der nichtalkoholischen und alkoholischen Fettlebererkrankung

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Der Pathologe

• Publication date

  2010-03-12

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00292-010-1274-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?

  2009cited by this paper
• Non-invasive evaluation of liver fibrosis using transient elastography.

  2008cited by this paper
• A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)

  2008cited by this paper
• Performance of transient elastography for the staging of liver fibrosis: a meta-analysis.

  2008cited by this paper
• Chemotherapie-assoziierte Hepatotoxizität in der Behandlung des kolorektalen Karzinoms (KRK)

  2008cited by this paper
• Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis.

  2008cited by this paper
• Sinusoidal Injury Increases Morbidity After Major Hepatectomy in Patients With Colorectal Liver Metastases Receiving Preoperative Chemotherapy

  2008cited by this paper
• Non-alcoholic steatohepatitis in children.

  2007cited by this paper
• Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease.

  2007cited by this paper
• Pathology of fatty liver disease

  2007cited by this paper
• Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future

  2007cited by this paper
• Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group.

  2007cited by this paper
• Update on non-alcoholic fatty liver disease in children.

  2007cited by this paper
• The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

  2007cited by this paper
• Prävalenz von Übergewicht und Adipositas bei deutschen Einschulkindern

  2007cited by this paper
• Current concepts in the pathogenesis of nonalcoholic fatty liver disease

  2007cited by this paper
• Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents.

  2007cited by this paper
• Pathogenesis of non-alcoholic steatohepatitis: human data.

  2007cited by this paper
• Pathogenesis and management issues for non-alcoholic fatty liver disease.

  2007cited by this paper
• Nichtalkoholische Fettleber

  2007cited by this paper
• In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

  2006cited by this paper
• Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease.

  2006cited by this paper
• When is steatosis too much for transplantation?

  2006cited by this paper
• LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

  2006cited by this paper
• Diagnostic evaluation of nonalcoholic fatty liver disease.

  2006cited by this paper
• Nonalcoholic fatty liver disease.

  2006cited by this paper
• Approaches to liver biopsy techniques--revisited.

  2006cited by this paper
• Influence of Preoperative Chemotherapy on the Risk of Major Hepatectomy for Colorectal Liver Metastases

  2006cited by this paper
• Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease

  2006cited by this paper
• Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C

  2006cited by this paper
• Non-alcoholic steatohepatitis: from cell biology to clinical practice.

  2006cited by this paper
• Non-alcoholic fatty liver disease: current concepts and management strategies.

  2006cited by this paper
• Chemotherapy-induced steatohepatitis in colorectal cancer patients.

  2006cited by this paper
• Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.

  2006cited by this paper
• Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

  2006cited by this paper
• Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

  2005cited by this paper
• Pathological features of NASH.

  2005cited by this paper
• Sources of variability in histological scoring of chronic viral hepatitis

  2005cited by this paper
• Histopathology of pediatric nonalcoholic fatty liver disease

  2005cited by this paper
• Pathology of nonalcoholic steatohepatitis.

  2005cited by this paper
• Nonalcoholic steatohepatitis: pathologic features and differential diagnosis.

  2005cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Proposal for a histological scoring and grading system for non‐alcoholic fatty liver disease

  2005cited by this paper
• Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis.

  2004cited by this paper
• Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.

  2004cited by this paper
• Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens.

  2004cited by this paper
• The epidemiology of fatty liver

  2004cited by this paper
• Alkoholische und nicht-alkoholische Steatohepatitis

  2004cited by this paper
• Role of liver biopsy in the assessment of non-alcoholic fatty liver disease.

  2004cited by this paper
• Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

  2003cited by this paper
• Diagnostik, Prognose und therapeutische Möglichkeiten der nicht-alkoholischen Fettlebererkrankung

  2003cited by this paper
• Concurrence of Histologic Features of Steatohepatitis with Other Forms of Chronic Liver Disease

  2003cited by this paper
• The natural history of nonalcoholic fatty liver disease: a clinical histopathological study

  2003cited by this paper
• Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

  2003cited by this paper
• Diagnosis of fatty liver disease: is biopsy necessary?

  2003cited by this paper
• Evolving pathophysiologic concepts in nonalcoholic steatohepatitis

  2002cited by this paper
• Pathology of steatohepatitis.

  2002cited by this paper
• Pathogenesis of steatohepatitis.

  2002cited by this paper
• Alcoholic and nonalcoholic steatohepatitis.

  2002cited by this paper
• Non‐alcoholic fatty liver disease

  2002cited by this paper
• NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

  2002cited by this paper
• Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

  2002cited by this paper
• Steatohepatitis in children.

  2002cited by this paper
• Nonalcoholic Steatohepatitis: Definition and Pathology

  2001cited by this paper
• Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes

  2001cited by this paper
• Analysis of liver allograft rejection related genes using cDNA-microarrays in liver allograft specimen.

  2001cited by this paper
• Nonalcoholic steatohepatitis in children.

  2000cited by this paper
• Relationship between aminotransferase levels and histopathological findings in patients with nonalcoholic steatohepatitis

  2000cited by this paper
• Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

  1999cited by this paper
• Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease

  1999cited by this paper
• Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

  1999cited by this paper
• Diagnosis and interpretation of steatosis and steatohepatitis.

  1998cited by this paper
• Steatohepatitis: a tale of two "hits"?

  1998cited by this paper
• REVIEW: Nonalcoholic steatohepatitis

  1997cited by this paper
• The natural history of nonalcoholic fatty liver: A follow‐up study

  1995cited by this paper
• Nonalcoholic steatohepatitis: an expanded clinical entity.

  1994cited by this paper
• Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

  1980cited by this paper

• Diagnostic Value of Ultrasound in Fatty Liver Disease

  2021cites this paper
• Alkoholische Lebererkrankungen (ALD)

  2020cites this paper
• Histopathologische Diagnostik und Differenzialdiagnostik der nichtalkoholischen Fettlebererkrankung

  2020cites this paper
• Fibrosis and alcohol-related liver disease.

  2019cites this paper
• Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD

  2019cites this paper
• EASL Clinical Practice Guidelines: Management of alcohol-related liver disease.

  2018cites this paper
• Genetik metabolischer und viraler Lebererkrankungen

  2017influential citation
• Age- and Gender Dependent Liver Fat Content in a Healthy Normal BMI Population as Quantified by Fat-Water Separating DIXON MR Imaging

  2015cites this paper
• Störungen der Ernährung

  2015cites this paper
• Metastases of pancreatic adenocarcinoma: A systematic review of literature and a new functional concept.

  2015cites this paper
• Effects of the compounds resveratrol, rutin, quercetin, and quercetin nanoemulsion on oxaliplatin-induced hepatotoxicity and neurotoxicity in mice

  2014cites this paper
• Update der S3-Leitlinie für das Pankreaskarzinom

  2014cites this paper
• Chronische Lebererkrankungen – neue Therapie

  2013cites this paper
• Die nichtalkoholische Steatohepatitis als viszerale Manifestation des metabolischen Syndroms

  2013cites this paper
• Ayurveda-Medizin bei Lebererkrankungen

  2012cites this paper
• Can the new RCP R0/R1 classification predict the clinical outcome in ductal adenocarcinoma of the pancreatic head?

  2012cites this paper
• Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist’s perspective

  2011cites this paper